ES480624A1 - A Purified Cancer Associated Protein - Google Patents
A Purified Cancer Associated ProteinInfo
- Publication number
- ES480624A1 ES480624A1 ES480624A ES480624A ES480624A1 ES 480624 A1 ES480624 A1 ES 480624A1 ES 480624 A ES480624 A ES 480624A ES 480624 A ES480624 A ES 480624A ES 480624 A1 ES480624 A1 ES 480624A1
- Authority
- ES
- Spain
- Prior art keywords
- cadet
- iac
- associated protein
- cancer associated
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 101710132631 Protein C1 Proteins 0.000 abstract 1
- 101710203837 Replication-associated protein Proteins 0.000 abstract 1
- 239000003599 detergent Substances 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 238000001114 immunoprecipitation Methods 0.000 abstract 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A purified protein (CaDet) which in SDS Page gradient shows a molecular weight of about 25,000 Daltons has been eluted from antibody affinity columns with immobilized antibodies specifically directed against the protein C1 IAC described in U.S. Patent No. 4,132,769, by elution with a detergent. CaDet reacts with anti C1 IAC in immunoprecipitation tests and, when used for immunization, CaDet gives increased titers of anti C1 IAC.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK216378 | 1978-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES480624A1 true ES480624A1 (en) | 1980-08-16 |
Family
ID=8110498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES480624A Expired ES480624A1 (en) | 1978-05-17 | 1979-05-16 | A Purified Cancer Associated Protein |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS5516291A (en) |
| AU (1) | AU521404B2 (en) |
| BE (1) | BE876301A (en) |
| DE (1) | DE2919833A1 (en) |
| ES (1) | ES480624A1 (en) |
| FI (1) | FI791551A (en) |
| FR (1) | FR2426055A1 (en) |
| GB (1) | GB2021593A (en) |
| IT (1) | IT7968046A0 (en) |
| LU (1) | LU81273A1 (en) |
| NL (1) | NL7903854A (en) |
| NO (1) | NO791643L (en) |
| NZ (1) | NZ190470A (en) |
| PT (1) | PT69617A (en) |
| SE (1) | SE7904276L (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0087898A1 (en) * | 1982-02-22 | 1983-09-07 | Cancer Research Campaign Technology Limited | Antibodies and antigens useful in the diagnosis and treatment of cancer |
| AU569467B2 (en) * | 1982-04-07 | 1988-02-04 | Baylor College Of Medicine | Immunoglobulin based cancer treating pharmaceutical compositions |
-
1979
- 1979-05-15 SE SE7904276A patent/SE7904276L/en not_active Application Discontinuation
- 1979-05-15 FI FI791551A patent/FI791551A/en not_active Application Discontinuation
- 1979-05-16 BE BE6/46832A patent/BE876301A/en unknown
- 1979-05-16 ES ES480624A patent/ES480624A1/en not_active Expired
- 1979-05-16 NO NO791643A patent/NO791643L/en unknown
- 1979-05-16 NZ NZ190470A patent/NZ190470A/en unknown
- 1979-05-16 PT PT69617A patent/PT69617A/en unknown
- 1979-05-16 DE DE19792919833 patent/DE2919833A1/en not_active Withdrawn
- 1979-05-16 FR FR7912426A patent/FR2426055A1/en not_active Withdrawn
- 1979-05-16 NL NL7903854A patent/NL7903854A/en not_active Application Discontinuation
- 1979-05-16 GB GB7917107A patent/GB2021593A/en not_active Withdrawn
- 1979-05-16 LU LU81273A patent/LU81273A1/en unknown
- 1979-05-17 AU AU47172/79A patent/AU521404B2/en not_active Ceased
- 1979-05-17 IT IT7968046A patent/IT7968046A0/en unknown
- 1979-05-17 JP JP6213379A patent/JPS5516291A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FR2426055A1 (en) | 1979-12-14 |
| JPS5516291A (en) | 1980-02-04 |
| SE7904276L (en) | 1979-11-18 |
| NO791643L (en) | 1979-11-20 |
| NL7903854A (en) | 1979-11-20 |
| AU521404B2 (en) | 1982-04-01 |
| PT69617A (en) | 1979-06-01 |
| IT7968046A0 (en) | 1979-05-17 |
| FI791551A (en) | 1979-11-18 |
| BE876301A (en) | 1979-11-16 |
| AU4717279A (en) | 1979-11-22 |
| NZ190470A (en) | 1982-06-29 |
| LU81273A1 (en) | 1979-09-10 |
| DE2919833A1 (en) | 1979-11-29 |
| GB2021593A (en) | 1979-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2106195T3 (en) | IGG AGLYCOSILATED ANTIBODY ANTI CD3. | |
| AU642403B2 (en) | Method for the use and synthesis of peptides | |
| EP0930365A3 (en) | Binding domains in serrate protein | |
| EP0420913A4 (en) | Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same | |
| GB2128630A (en) | Method of affinity purification employing monoclonal antibodies | |
| EP0517853A4 (en) | Method for detection of -i(borrelia burgdorferi), purified antigen thereof and antibody capable of binding therewith | |
| IL92037A0 (en) | Novel family of high affinity,modified antibodies for cancer treatment | |
| AU1378395A (en) | Metal chelators | |
| CA2080548A1 (en) | Monoclonal antibodies to hepatitis c virus | |
| ES480624A1 (en) | A Purified Cancer Associated Protein | |
| AU2032988A (en) | A genus-specific listeria antigen identified by monoclonal antibodies | |
| AU7796291A (en) | High affinity antibodies to small peptides | |
| EP0734451A4 (en) | ENTEROTOXINS OF -i(SHIGELLA FLEXNERI) 2a | |
| Hudson et al. | The use of column-bound B lymphocytes for absorption of antisera to T lymphocyte antigens | |
| DE3273844D1 (en) | Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor | |
| WO1994021812A3 (en) | Hepatitis b escape mutant specific binding molecules | |
| SE8502722L (en) | SET TO DETERMINE FC PART BINDING Bacterial POLYPEPTIDES | |
| AU7955687A (en) | Method for purification of antibodies | |
| IE860758L (en) | Anaplasma marginale subunit antigen for vaccination and¹diagnosis | |
| AU1626492A (en) | Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof | |
| AU6596390A (en) | Monoclonal antibodies cross-reactive and cross-protective against p. aeruginosa serotypes | |
| EP0313538A3 (en) | Monoclonal antibody, a process for its preparation and the use thereof | |
| AU653182B2 (en) | Process for selective removal of salivary alpha-amylase and assay for pancreatic alpha-amylase | |
| MY102245A (en) | Purification of antibodies | |
| Fishwild | ON THE IMMUNOCHEMICAL AND BIOCHEMICAL DEFINITION OF A NUCLEAR ANTIGEN SCL-70 REACTIVE WITH AUTOANTIBODIES IN PROGRESSIVE SYSTEMATIC SCLEROSIS. |